Tricida, Inc.
DelistedCIK 1595585fmd_0SNMA83ACGK6YK3QE1TCHV3760Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2016 to Sep 30, 2022, 24 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|---|
| Research and development | 22 | 36 | 86 | 133 | 148 | 115 |
| Selling, general and administrative | 5 | 11 | 18 | 46 | 103 | 38 |
| Total operating expenses | 27 | 47 | 104 | 179 | 251 | 153 |
| Operating income | (27) | (47) | (104) | (179) | (251) | (153) |
| Interest expense | 0 | 0 | 3 | 6 | 18 | 18 |
| Interest and investment income | 0 | 0 | 4 | 9 | 4 | 1 |
| Other non-operating income (expense) | 0 | 0 | 4 | 8 | 5 | 0 |
| Income tax expense | – | 0 | 0 | (0) | 0 | 0 |
| Net income | (29) | (41) | (103) | (177) | (265) | (177) |